Pasar al contenido principal

EFECTOS DE LA VITAMINA D SOBRE LAS CELULAS TRONCALES Y EL MICROAMBIENTE TUMORAL EN CANCER DE COLON: DIFERENCIACION, METABOLISMO Y COMUNICACION INTERCELULAR

PID2022-136729OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Vitamin D opposes multilineage cell differentiation induced by Notch inhibition and BMP4 pathway activation in human colon organoids

  • Bustamante Madrid, Pilar
  • Barbáchano, Antonio
  • Albandea Rodríguez, David
  • Rodríguez Cobos, Javier
  • Rodríguez Salas, Nuria
  • Prieto Nieto, Isabel
  • Burgos García, Aurora
  • Martínez de Villarreal, Jaime
  • Real, Francisco X.
  • González Sancho, José Manuel
  • Larriba, María Jesús
  • Lafarga, Miguel
  • Muñoz, Alberto
  • Fernández Barral, Asunción
Understanding the mechanisms involved in colonic epithelial differentiation is key to unraveling the alterations causing inflammatory conditions and cancer. Organoid cultures provide an unique tool to address these questions but studies are scarce. We report a differentiation system toward enterocytes and goblet cells, the two major colonic epithelial cell lineages, using colon organoids generated from healthy tissue of colorectal cancer patients. Culture of these organoids in medium lacking stemness agents resulted in a modest ultrastructural differentiation phenotype with low-level expression of enterocyte (KLF4, KRT20, CA1, FABP2) and goblet cell (TFF2, TFF3, AGR2) lineage markers. BMP pathway activation through depletion of Noggin and addition of BMP4 resulted in enterocyte-biased differentiation. Contrarily, blockade of the Notch pathway using the γ-secretase inhibitor dibenzazepine (DBZ) favored goblet cell differentiation. Combination treatment with BMP4 and DBZ caused a balanced strong induction of both lineages. In contrast, colon tumor organoids responded poorly to BMP4 showing only weak signals of cell differentiation, and were unresponsive to DBZ. We also investigated the effects of 1α,25-dihydroxyvitamin D3 (calcitriol) on differentiation. Calcitriol attenuated the effects of BMP4 and DBZ on colon normal organoids, with reduced expression of differentiation genes and phenotype. Consistently, in normal organoids, calcitriol inhibited early signaling by BMP4 as assessed by reduction of the level of phospho-SMAD1/5/8. Our results show that BMP and Notch signaling play key roles in human colon stem cell differentiation to the enterocytic and goblet cell lineages and that calcitriol modulates these processes favoring stemness features., This work was supported by grant PID2019-104867RB-I00 funded by MCIN/AEI/10.13039/501100011033; grant PID2022-136729OB-I00 funded by MCIN/AEI/10.13039/501100011033 and “ERDF A way of making Europe”; grant S2022/BMD-7212 funded by Comunidad de Madrid; and grants ICI20/00057, CIBERONC/CB16/12/00273, CIBERONC/CB16/12/00453 and CIBERONC/CB16/12/00398 funded by the Instituto de Salud Carlos III - Fondo Europeo de Desarrollo Regional. PB-M and DA-R were supported by grants BES-2017-082483 and PRE2020-092713, respectively, funded by MCIN/AEI/10.13039/501100011033 and “ESF Investing in your future”. PB-M, AB, DA-R, JR-C, JMG-S, MJL, AM and AF-B belong to the Spanish National Research Council (CSIC)‘s Cancer Hub.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

A plastic EMP1+ to LGR5+ cell state conversion as a bypass to KRASG12D pharmacologic inhibition in metastatic colorectal cancer

  • Centonze, Alessia
  • Novillo-Font, Meritxell
  • Novell, Mireia
  • Martí Renom, Marc A.
  • Batlle Gómez, Eduard
Inhibitors of the oncogene KRAS hold promise for treating metastatic colorectal cancer (mCRC). In this study, we show that a selective, covalent small-molecule inhibitor of the active (ON) conformation of RAS-G12D, RMC-9945, exerts durable disease control in preclinical colorectal cancer models of early liver metastasis, but its therapeutic activity was diminished in the advanced metastatic disease. RMC-9945-treated metastases underwent a transition from a poor prognosis-associated Emp1+ transcriptional state to a WNT-driven Lgr5+ stem cell-like state that withstands the absence of RAS-G12D activity. This cell state change occurred within hours of RAS(ON) inhibitor treatment through a shift in transcription factor usage that involved limited chromatin remodeling. Forced conversion of metastatic cells to the Lgr5+ state through RAS-G12D inhibition, followed by genetic ablation of this population, reduced metastatic burden and prolonged survival in a mouse mCRC model. Overall, these preclinical findings demonstrate a central role for oncogenic KRAS in governing cellular plasticity in mCRC. Significance: We show that inhibition of oncogenic KRAS in preclinical models of advanced mCRC exerts a limited benefit, primarily due to the reversion of tumor cells to a stem cell-like state. Our findings highlight the context-dependent effects of oncogenic KRAS mutations and underscore cell plasticity as a therapeutic opportunity. See related commentary by Eng and Yilmaz et al., p. 201., This research has also been funded by ERC advanced grants 884623 (residualCRC), La Caixa Foundation (HR24_00447), Ministerio de Ciencia e Innovación (PID2023-153116OB-I00), Persist_Seq consortium (IMI), La Generalitat de Catalunya (2021 SGR 001278) and CRC STARS (GEACC248909TABE, funded by CRUK-AECC). A. Centonze is supported by EMBO postdoctoral fellowship (ALTF 61-2023). A. Barbachano is supported by CIBERONC. The A. Muñoz laboratory is funded by MICINN (PID22-136729OB-I00). M.A. Marti-Renom and M. Novillo-Font acknowledge support by the Spanish Ministerio de Ciencia e Innovación (PID2023-151484NB-I00 and FPU20/05004, respectively). M.A. Marti-Renom also acknowledges support from Generalitat de Catalunya (2021-SGR-01127).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

From molecular basis to clinical insights: a challenging future for the vitamin D endocrine system in colorectal cancer

  • Pereira, Fábio
  • Fernández-Barral, Asunción
  • Larriba, María Jesús
  • Barbáchano, Antonio
  • González-Sancho, José Manuel
Colorectal cancer (CRC) is one of the most life-threatening neoplasias in terms of incidence and mortality worldwide. Vitamin D deficiency has been associated with an increased risk of CRC. 1α,25-Dihydroxyvitamin D3 [1,25(OH)2D3], the most active vitamin D metabolite, is a pleiotropic hormone that, through its binding to a transcription factor of the nuclear receptor superfamily, is a major regulator of the human genome. 1,25(OH)2D3 acts on colon carcinoma and stromal cells and displays tumor protective actions. Here, we review the variety of molecular mechanisms underlying the effects of 1,25(OH)2D3 in CRC, which affect multiple processes that are dysregulated during tumor initiation and progression. Additionally, we discuss the epidemiological data that associate vitamin D deficiency and CRC, and the most relevant randomized controlled trials of vitamin D3 supplementation conducted in both healthy individuals and CRC patients., The work in the authors' laboratory is funded by the Agencia Estatal de Investigación (PID2019-104867RB-I00 and PID2022-136729OB-I00; MCIN/AEI/10.13039/501100011033), the Instituto de Salud Carlos III – Fondo Europeo de Desarrollo Regional (CIBERONC/CB16/12/00273 and ICI20/00057), and the Comunidad de Madrid (S2022/BMD-7212). AF-B, MJL, AB, and JMG-S belong to the Spanish National Research Council (CSIC)'s Cancer Hub., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Vitamin D opposes multilineage cell differentiation induced by Notch inhibition and BMP4 pathway activation in human colon organoids

  • Bustamante-Madrid, Pilar
  • Barbáchano, Antonio
  • Albandea-Rodríguez, David
  • Rodríguez-Cobos, Javier
  • Rodríguez-Salas, Nuria
  • Prieto, Isabel
  • Burgos, Aurora
  • Martínez de Villarreal, Jaime
  • Real, Francisco X.
  • González-Sancho, José Manuel
  • Larriba, María Jesús
  • Lafarga, Miguel
  • Muñoz Terol, Alberto
  • Fernández-Barral, Asunción
Understanding the mechanisms involved in colonic epithelial differentiation is key to unraveling the alterations causing inflammatory conditions and cancer. Organoid cultures provide an unique tool to address these questions but studies are scarce. We report a differentiation system toward enterocytes and goblet cells, the two major colonic epithelial cell lineages, using colon organoids generated from healthy tissue of colorectal cancer patients. Culture of these organoids in medium lacking stemness agents resulted in a modest ultrastructural differentiation phenotype with low-level expression of enterocyte (KLF4, KRT20, CA1, FABP2) and goblet cell (TFF2, TFF3, AGR2) lineage markers. BMP pathway activation through depletion of Noggin and addition of BMP4 resulted in enterocyte-biased differentiation. Contrarily, blockade of the Notch pathway using the γ-secretase inhibitor dibenzazepine (DBZ) favored goblet cell differentiation. Combination treatment with BMP4 and DBZ caused a balanced strong induction of both lineages. In contrast, colon tumor organoids responded poorly to BMP4 showing only weak signals of cell differentiation, and were unresponsive to DBZ. We also investigated the effects of 1α,25-dihydroxyvitamin D3 (calcitriol) on differentiation. Calcitriol attenuated the effects of BMP4 and DBZ on colon normal organoids, with reduced expression of differentiation genes and phenotype. Consistently, in normal organoids, calcitriol inhibited early signaling by BMP4 as assessed by reduction of the level of phospho-SMAD1/5/8. Our results show that BMP and Notch signaling play key roles in human colon stem cell differentiation to the enterocytic and goblet cell lineages and that calcitriol modulates these processes favoring stemness features., This work was supported by grant PID2019-104867RB-I00 funded by MCIN/AEI/10.13039/501100011033; grant PID2022-136729OB-I00 funded by MCIN/AEI/10.13039/501100011033 and “ERDF A way of making Europe”; grant S2022/BMD-7212 funded by Comunidad de Madrid; and grants ICI20/00057, CIBERONC/CB16/12/00273, CIBERONC/CB16/12/00453 and CIBERONC/CB16/12/00398 funded by the Instituto de Salud Carlos III - Fondo Europeo de Desarrollo Regional. PB-M and DA-R were supported by grants BES-2017-082483 and PRE2020-092713, respectively, funded by MCIN/AEI/10.13039/501100011033 and “ESF Investing in your future”. PB-M, AB, DA-R, JR-C, JMG-S, MJL, AM and AF-B belong to the Spanish National Research Council (CSIC)‘s Cancer Hub., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

SIRT1 Mediates the Antagonism of Wnt/β-Catenin Pathway by Vitamin D in Colon Carcinoma Cells

  • García-Martínez, José Manuel
  • Chocarro-Calvo, Ana
  • Martínez-Useros, Javier
  • Regueira-Acebedo, Nerea
  • Fernandez-Aceñero, M. Jesús
  • Muñoz, Alberto
  • Larriba, María Jesús
  • García-Jiménez, Custodia
Cancer initiation and progression result from genetic and epigenetic alterations caused by interactions between environmental and endogenous factors leading to aberrant cell signalling. Colorectal cancers (CRC) are linked to abnormal activation of the Wnt/β-catenin pathway, whose key feature is the nuclear accumulation of acetylated β-catenin in colon epithelial cells. Nuclear β-catenin acts as a transcriptional co-activator, targeting genes involved in cell proliferation and invasion. 1α,25-Dihydroxyvitamin D3 (1,25(OH)2D3 or calcitriol), the active form of vitamin D, antagonizes Wnt/β-catenin over-activation by engaging its high affinity receptor, VDR. Here we unveil that 1,25(OH)2D3-bound VDR activates Silent Information Regulator of Transcription, sirtuin 1 (SIRT1), leading to β-catenin deacetylation and nuclear exclusion, downregulation of its pro-tumourigenic target genes and inhibition of human colon carcinoma cell proliferation. Notably, orthogonal SIRT1 activation mimics nuclear exclusion of β-catenin while SIRT1 inhibition blocks the effects of 1,25(OH)2D3. Thus, SIRT1 emerges as a crucial mediator in the protective action of vitamin D against CRC. The mutual negative feedback loop unveiled here between Wnt and SIRT1 represents an important surrogate target in CRC. Since nuclear localisation of β-catenin is a critical driver of CRC that requires its acetylation, we provide a mechanistic foundation for the epidemiological evidence linking vitamin D deficiency and increased CRC risk and mortality., Funding for this work was provided by the Agencia Estatal de Investigación MCIN/AEI/10.13039/501100011033 (PID2019-104867RB-I00); Agencia Estatal de Investigación MCIN/AEI/10.13039/501100011033 and FEDER Una manera de hacer Europa (PID2021-127645OA-I00 and PID2022-136729OB-I00); Comunidad de Madrid (PEJ-2021-AI/BMD-22973 and PEJ-2021-TL/BMD-21515; Ayudas Atracción de Talento 2017-T1/BMD-5334 and 2021-5A/BMD-20951; A385-DROPLET Young Researchers R&D Project 2019 CAM-URJC; PRECICOLON-CM, P2022/BMD-7212); Universidad Rey Juan Carlos (ADIPOMELM, Proyecto Puente de Investigación 2020); and Instituto de Salud Carlos III, Fondo Europeo de Desarrollo Regional (CIBER-ONC/CB16/12/00273)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Vitamin D deficiency induces erectile dysfunction: Role of superoxide and Slpi

  • Olivencia, Miguel A.
  • Climent, Belén
  • Barreira, Bianca
  • Morales-Cano, Daniel
  • Sánchez, Ana
  • Fernández, Argentina
  • García-Gómez, Borja
  • Romero-Otero, Javier
  • Rodríguez, Claudia
  • Moreno, Laura
  • Prieto, Dolores
  • Larriba, María Jesús
  • Cogolludo, Angel
  • Angulo, Javier
  • Pérez-Vizcaíno, Francisco
[Background and Purpose] Epidemiological studies suggest a relationship between vitamin D deficiency and erectile dysfunction (ED). We hypothesized that vitamin D deficiency or vitamin D receptor (VDR) knockout causes ED and analysed the underlying molecular mechanisms., [Experimental Approach] Erectile function was assessed in vivo in anaesthetized male mice or rats by evaluating intracavernosal pressure (ICP) and in vitro in male Vdr−/− mice, and rat or human isolated corpora cavernosa (CCs) mounted in a myograph. Bulk RNA-sequencing (RNA-seq) transcriptomic analysis was performed in rat CCs. Vitamin D deficiency was induced in rats fed a vitamin D-free diet for 5 months., [Key Results] CCs from human donors with low plasma vitamin D exhibited reduced nitric oxide (NO)-dependent erectile function. This ED was also reproduced in vitamin D-deficient rats and VDR knockout mice, in vivo and ex vivo, and is associated with penile fibrosis and reduced response to the phosphodiesterase 5 inhibitor (PDE5i) sildenafil. CCs from deficient rats show increased superoxide levels, and their impaired erectile function was restored by superoxide scavengers. Transcriptomic analysis, real-time polymerase chain reaction (RT-PCR) and Western blot showed down-regulated secretory leukocyte protease inhibitor (Slpi). Moreover, recombinant SLPI prevented superoxide-induced ED, while Slpi gene silencing led to reduced erectile function in a superoxide-dependent manner., [Conclusion and Implications] Vitamin D deficiency or VDR knockout reduces erectile function. We suggest that this effect is mediated by increased superoxide levels and down-regulation of SLPI. Vitamin D deficiency might be an aetiological factor for vascular ED and for the therapeutic failure of PDE5i., The work is funded by the Agencia Estatal de Investigación (PID2019-107363RB-I00, PID2019-104867RB-I00, PID2020-117939RB-I00 and PID2022-136729OB-I00, funded by MCIN) and the Instituto de Salud Carlos III—Fondo Europeo de Desarrollo Regional (CIBERES/CB06/06/1084, CIBERONC/CB16/12/00273 and PI22/01302). MJL belongs to the Spanish National Research Council's (CSIC) Cancer Hub. MAO is funded by Universidad Complutense de Madrid—Banco Santander (CT63/19-CT64/19)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Calcitriol modulates age-dependent drug response in paired patient-derived normal and tumor colorectal organoids

  • Fernández-Barral, Asunción
  • Barbáchano, Antonio
  • Rodríguez-Marrero, Silvia
  • Peso, Luis del
  • Herreros-Cabello, Alfonso
  • Arroyo-Gascón, Estrella
  • Rodríguez-Salas, Nuria
  • Prieto, Isabel
  • Burgos, Aurora
  • León-Arellano, Miguel
  • García-Olmo, Damián
  • Olleros, Tomás
  • González-Sancho, José Manuel
  • Larriba, María Jesús
  • Muñoz, Alberto
The incidence of early-onset colorectal cancer (EO-CRC, <50 years) is rising worldwide, highlighting the need to better understand the underlying causes of this age-related divergence. We used paired patient-derived normal and tumor colorectal organoids to investigate the therapeutic window of chemotherapeutic agents and its modulation by calcitriol (the most active vitamin D metabolite). Dose-response analyses revealed marked interpatient variability, with SN38 being more potent than 5-fluorouracil (5-FU) and oxaliplatin. Normal organoids were more resistant than paired tumor counterparts to 5-FU and oxaliplatin in both EO-CRC and late-onset CRC (LO-CRC, >50 years), indicating selective tumor cytotoxicity. In contrast, the therapeutic window for SN38 was preserved in LO-CRC but not in EO-CRC organoids, revealing age-dependent differences in drug sensitivity. Moreover, calcitriol reduced the cytotoxicity of 5-FU and SN38 in normal organoids regardless of patient age, while in tumor organoids this protective effect was restricted to EO-CRC. As a consequence, calcitriol treatment selectively expanded the therapeutic window for 5-FU and SN38 in LO-CRC organoids. Mechanistically, these effects correlated with calcitriol-induced antiproliferative action and transcriptional regulation of drug metabolism-related pathways. Overall, our findings identify age-dependent differences in chemotherapy response and support the importance of maintaining adequate vitamin D status to reduce chemotherapy-associated toxicity., This study has been funded by Instituto de Salud Carlos III (ISCIII) through the project ICI20/00057 and co-funded by the European Union. Additional support was provided by grants CIBERONC/CB16/12/00273, CIBERONC/CB16/12/00398, and CIBERES/CB15/00037 funded by the Instituto de Salud Carlos III (ISCIII) - FEDER, UE. This work was also supported by grant PID2019-104867RB-I00 funded by MICIU/AEI/10.13039/501100011033; grant PID2022-136729OB-I00 funded by MICIU/AEI/10.13039/501100011033 and FEDER, UE and grant S2022/BMD-7212 funded by Comunidad de Madrid. SR-M was supported by grant PREP2022-000611 funded by MICIU/AEI/10.13039/501100011033 and FSE+. EA-G was supported by grant FPU24/03135 funded by Ministerio de Ciencia, Innovación y Universidades. AF-B, AB, SR-M, AH-C, EA-G, JMG-S, MJL and AM belong to the Spanish National Research Council (CSIC)'s Cancer Hub., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Vitamin D opposes multilineage cell differentiation induced by Notch inhibition and BMP4 pathway activation in human colon organoids

  • Bustamante Madrid, Pilar
  • Barbáchano, Antonio
  • Albandea Rodríguez, David
  • Rodríguez Cobos, Javier
  • Rodríguez Salas, Nuria
  • Prieto Nieto, Isabel
  • Burgos García, Aurora
  • Martínez de Villarreal, Jaime
  • Real, Francisco X.
  • González Sancho, José Manuel
  • Larriba, María Jesús
  • Lafarga, Miguel
  • Muñoz, Alberto
  • Fernández Barral, Asunción
Understanding the mechanisms involved in colonic epithelial differentiation is key to unraveling the alterations causing inflammatory conditions and cancer. Organoid cultures provide an unique tool to address these questions but studies are scarce. We report a differentiation system toward enterocytes and goblet cells, the two major colonic epithelial cell lineages, using colon organoids generated from healthy tissue of colorectal cancer patients. Culture of these organoids in medium lacking stemness agents resulted in a modest ultrastructural differentiation phenotype with low-level expression of enterocyte (KLF4, KRT20, CA1, FABP2) and goblet cell (TFF2, TFF3, AGR2) lineage markers. BMP pathway activation through depletion of Noggin and addition of BMP4 resulted in enterocyte-biased differentiation. Contrarily, blockade of the Notch pathway using the γ-secretase inhibitor dibenzazepine (DBZ) favored goblet cell differentiation. Combination treatment with BMP4 and DBZ caused a balanced strong induction of both lineages. In contrast, colon tumor organoids responded poorly to BMP4 showing only weak signals of cell differentiation, and were unresponsive to DBZ. We also investigated the effects of 1α,25-dihydroxyvitamin D3 (calcitriol) on differentiation. Calcitriol attenuated the effects of BMP4 and DBZ on colon normal organoids, with reduced expression of differentiation genes and phenotype. Consistently, in normal organoids, calcitriol inhibited early signaling by BMP4 as assessed by reduction of the level of phospho-SMAD1/5/8. Our results show that BMP and Notch signaling play key roles in human colon stem cell differentiation to the enterocytic and goblet cell lineages and that calcitriol modulates these processes favoring stemness features., This work was supported by grant PID2019-104867RB-I00 funded by MCIN/AEI/10.13039/501100011033; grant PID2022-136729OB-I00 funded by MCIN/AEI/10.13039/501100011033 and “ERDF A way of making Europe”; grant S2022/BMD-7212 funded by Comunidad de Madrid; and grants ICI20/00057, CIBERONC/CB16/12/00273, CIBERONC/CB16/12/00453 and CIBERONC/CB16/12/00398 funded by the Instituto de Salud Carlos III - Fondo Europeo de Desarrollo Regional. PB-M and DA-R were supported by grants BES-2017-082483 and PRE2020-092713, respectively, funded by MCIN/AEI/10.13039/501100011033 and “ESF Investing in your future”. PB-M, AB, DA-R, JR-C, JMG-S, MJL, AM and AF-B belong to the Spanish National Research Council (CSIC)‘s Cancer Hub.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A plastic EMP1+ to LGR5+ cell state conversion as a bypass to KRASG12D pharmacologic inhibition in metastatic colorectal cancer

  • Centonze, Alessia
  • Novillo-Font, Meritxell
  • Novell, Mireia
  • Martí Renom, Marc A.
  • Batlle Gómez, Eduard
Inhibitors of the oncogene KRAS hold promise for treating metastatic colorectal cancer (mCRC). In this study, we show that a selective, covalent small-molecule inhibitor of the active (ON) conformation of RAS-G12D, RMC-9945, exerts durable disease control in preclinical colorectal cancer models of early liver metastasis, but its therapeutic activity was diminished in the advanced metastatic disease. RMC-9945-treated metastases underwent a transition from a poor prognosis-associated Emp1+ transcriptional state to a WNT-driven Lgr5+ stem cell-like state that withstands the absence of RAS-G12D activity. This cell state change occurred within hours of RAS(ON) inhibitor treatment through a shift in transcription factor usage that involved limited chromatin remodeling. Forced conversion of metastatic cells to the Lgr5+ state through RAS-G12D inhibition, followed by genetic ablation of this population, reduced metastatic burden and prolonged survival in a mouse mCRC model. Overall, these preclinical findings demonstrate a central role for oncogenic KRAS in governing cellular plasticity in mCRC. Significance: We show that inhibition of oncogenic KRAS in preclinical models of advanced mCRC exerts a limited benefit, primarily due to the reversion of tumor cells to a stem cell-like state. Our findings highlight the context-dependent effects of oncogenic KRAS mutations and underscore cell plasticity as a therapeutic opportunity. See related commentary by Eng and Yilmaz et al., p. 201., This research has also been funded by ERC advanced grants 884623 (residualCRC), La Caixa Foundation (HR24_00447), Ministerio de Ciencia e Innovación (PID2023-153116OB-I00), Persist_Seq consortium (IMI), La Generalitat de Catalunya (2021 SGR 001278) and CRC STARS (GEACC248909TABE, funded by CRUK-AECC). A. Centonze is supported by EMBO postdoctoral fellowship (ALTF 61-2023). A. Barbachano is supported by CIBERONC. The A. Muñoz laboratory is funded by MICINN (PID22-136729OB-I00). M.A. Marti-Renom and M. Novillo-Font acknowledge support by the Spanish Ministerio de Ciencia e Innovación (PID2023-151484NB-I00 and FPU20/05004, respectively). M.A. Marti-Renom also acknowledges support from Generalitat de Catalunya (2021-SGR-01127).